Aptevo Therapeutics Inc (APVO)
0.7616
+0.05
(+6.89%)
USD |
NASDAQ |
Apr 18, 16:00
0.7588
0.00 (0.00%)
After-Hours: 20:00
Aptevo Therapeutics Debt to Equity Ratio
Debt to Equity Ratio Chart
Historical Debt to Equity Ratio Data
Date | Value |
---|---|
March 31, 2022 | -0.8165 |
December 31, 2021 | 12.64 |
September 30, 2021 | 2.082 |
June 30, 2021 | 1.080 |
March 31, 2021 | 1.407 |
December 31, 2020 | 1.510 |
September 30, 2020 | 11.44 |
June 30, 2020 | 0.00 |
March 31, 2020 | 0.00 |
December 31, 2019 | 1.677 |
September 30, 2019 | 0.9981 |
June 30, 2019 | 0.7465 |
March 31, 2019 | 0.4962 |
Date | Value |
---|---|
December 31, 2018 | 0.634 |
September 30, 2018 | 0.4351 |
June 30, 2018 | 0.3492 |
March 31, 2018 | 0.2824 |
December 31, 2017 | 0.2324 |
September 30, 2017 | 0.1936 |
June 30, 2017 | 0.3645 |
March 31, 2017 | 0.2998 |
December 31, 2016 | 0.3635 |
September 30, 2016 | 0.2841 |
June 30, 2016 | 0.00 |
March 31, 2016 | 0.00 |
December 31, 2015 | 0.00 |
Debt to Equity Ratio Definition
The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.
Debt to Equity Ratio Range, Past 5 Years
-0.8165
Minimum
Mar 2022
12.64
Maximum
Dec 2021
2.731
Average
1.244
Median
Debt to Equity Ratio Benchmarks
Debt to Equity Ratio Related Metrics
Total Assets (Quarterly) | 24.84M |
Total Liabilities (Quarterly) | 12.62M |
Shareholders Equity (Quarterly) | 12.22M |